Matthew I. Milowsky, MD of North Carolina at Chapel Hill School of Medicine discusses how genomics are changing the way bladder cancer subtypes are being treated at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.
How Genomics are Changing Treatment for Bladder Cancer Subtypes
